When Thomas Edison died, or Einstein, or Dr. Feynman, for that matter… we knew what we had lost. The scientific community grieved. But when a scientist whose discovery might prove to be in any one or even all of their leagues died on Feb. 18 of last year, it felt as though the news went almost unnoticed. Gunter Blobel was a molecular biologist. In 1999, he was awarded the Nobel Prize in medicine. He had determined that proteins in any living cell have a sort of ZIP code system that guides them to where they need to go to take… Read More

When Thomas Edison died, or Einstein, or Dr. Feynman, for that matter… we knew what we had lost. The scientific community grieved. But when a scientist whose discovery might prove to be in any one or even all of their leagues died on Feb. 18 of last year, it felt as though the news went almost unnoticed. Gunter Blobel was a molecular biologist. In 1999, he was awarded the Nobel Prize in medicine. He had determined that proteins in any living cell have a sort of ZIP code system that guides them to where they need to go to take care of tissue, organs, and biochemistry. Blobel’s mentor at Rockefeller University, Dr. George Palade, was a wizard with electron microscopes — his work earned him the Nobel in 1974. Blobel figured out that there are about a quadrillion cells in the human body, each containing about a billion protein molecules that are spun out of little cavities known as endoplasmic reticula. These proteins are all guarded by special membranes. He and a colleague hypothesized that each of these proteins also contains proteins that act as airport luggage tags, as his obituary in the Times put it. It turns out this… Read More

For biotech investors, the year has started with a bang. First, it was Bristol-Myers Squibb’s (NYSE: BMY) enormous $74 billion bid for Celgene (Nasdaq: CELG), one of the largest biotech companies in the world. Right on its heels came a smaller but still significant move — the announcement on Jan. 7 of Eli Lilly’s (NYSE: LLY) intended $8 billion acquisition of Loxo Oncology (Nasdaq: LOXO). —Recommended Link— Market Rally Forecast For The Next 3 Days Did you know the stock market rallied during every government shutdown over the past 25 years? In fact, this time,… Read More

For biotech investors, the year has started with a bang. First, it was Bristol-Myers Squibb’s (NYSE: BMY) enormous $74 billion bid for Celgene (Nasdaq: CELG), one of the largest biotech companies in the world. Right on its heels came a smaller but still significant move — the announcement on Jan. 7 of Eli Lilly’s (NYSE: LLY) intended $8 billion acquisition of Loxo Oncology (Nasdaq: LOXO). —Recommended Link— Market Rally Forecast For The Next 3 Days Did you know the stock market rallied during every government shutdown over the past 25 years? In fact, this time, it’s already up 10%… and still going. There’s a trade that exploits this situation exceptionally well, and you can take advantage of it over the next 3 days. You can find the full details here. I think we can expect even more deals as the year progresses. And that, of course, is potentially great news for investors… There are several industry-specific factors making it imperative that the flow of deals continues. For several years now, large pharma has been facing a crisis of sorts. The business model of drug companies has long been based on having… Read More

This may be the year we see retail roar back. If you remove the last quarter of 2018, the sector posted strong performance numbers. Surging behind low unemployment, climbing consumer confidence, and a better-than-expected holiday season, retail hit fresh highs in 2018. Then, along with the rest of the market, the bottom fell out in December with stocks plunging to their worse end-of-year performance since the Great Depression. —Recommended Link— Wall Street Won’t Tell You About This… But We Just Uncovered A Bombshell… I’ve created an in-depth report for this opportunity and it covers what I believe is the… Read More

This may be the year we see retail roar back. If you remove the last quarter of 2018, the sector posted strong performance numbers. Surging behind low unemployment, climbing consumer confidence, and a better-than-expected holiday season, retail hit fresh highs in 2018. Then, along with the rest of the market, the bottom fell out in December with stocks plunging to their worse end-of-year performance since the Great Depression. —Recommended Link— Wall Street Won’t Tell You About This… But We Just Uncovered A Bombshell… I’ve created an in-depth report for this opportunity and it covers what I believe is the biggest investment opportunity we’ll see in our lifetime… It will change the concept of what it means to be human, as we see major diseases eradicated… and as our life expectancy reaches 120 years. I’ve been tracking this development for seven years… At the same time, consumer confidence remains high, oil prices low, and employment solid in the face of the retail rout. Add in the abating Chinese tariff pressures and a bullish picture is painted for retail and the overall market in 2019. #-ad_banner-#Strategically buying dips is a time-honored way to profit from the stock market. December beat retail… Read More

The next week will be an interesting week in the stock market. Of course, there’s never any shortage of events that could change the outlook for the market one way or another… But according to a chart of the S&P 500, it looks like we’re at an important technical resistance level. Resistance is an important technical term for a price level where a security’s advance is expected to stall. In other words, it’s a price level where sellers appear, and their actions can often be anticipated. In the chart below, I’ve labeled three factors that are all pointing toward resistance… Read More

The next week will be an interesting week in the stock market. Of course, there’s never any shortage of events that could change the outlook for the market one way or another… But according to a chart of the S&P 500, it looks like we’re at an important technical resistance level. Resistance is an important technical term for a price level where a security’s advance is expected to stall. In other words, it’s a price level where sellers appear, and their actions can often be anticipated. In the chart below, I’ve labeled three factors that are all pointing toward resistance near the S&P 500’s current level around 2,600… 1. The March lows (blue dashed line): Many investors like to buy stocks when they approach previous lows, as it often represents a “safe” bargain price. We saw this in action back in October and November, when stocks fell to their March lows (which then represented “support”) and were met with aggressive buying. However, stocks suffered a rapid loss in December, so anyone who bought at last year’s lows is just getting back to even. From what I’ve observed, many traders tend to sell the moment their positions get back… Read More

Money and health… As the calendar flips over to a new year, these two areas of our lives tend to become a focal point for improvement. On the money side of things, we assess our financial house and set goals (read resolutions) to pay down debt, save more, increase income, and reevaluate our retirement strategy. —Recommended Link— How To Play The Government Shutdown For Maximum Portfolio Gain Since the government has shut its doors, the market has already soared 10%. Here’s the best trade to profit from it over the next week. Read More

Money and health… As the calendar flips over to a new year, these two areas of our lives tend to become a focal point for improvement. On the money side of things, we assess our financial house and set goals (read resolutions) to pay down debt, save more, increase income, and reevaluate our retirement strategy. —Recommended Link— How To Play The Government Shutdown For Maximum Portfolio Gain Since the government has shut its doors, the market has already soared 10%. Here’s the best trade to profit from it over the next week. Click here. On the health side of the equation, we want to lose weight, eat healthier, and build muscle. Gym memberships typically skyrocket this time of year, diet books are sold out, and health-monitoring devices fly off the shelves.  It’s no surprise that these are the two areas that receive the most attention. After all, household debt totaled $13.5 trillion at the end of last year’s third quarter — an all-time high. When looking only at credit card debt, student, auto, and personal loans, that figure stood at nearly $4 trillion, surpassing the previous high-water mark set in the… Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this year, nearly four-fold the return on the S&P 500, after having crashed 11.8% last year. Valuation multiples are down and acquisition activity for 2019 is already 26% of last year’s total. —Recommended Link— How To Make Massive Gains When The Market Tumbles Industry veteran invites 50 investors to join him in the world’s only legal market hack that actually works… discover how to bring home an… Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this year, nearly four-fold the return on the S&P 500, after having crashed 11.8% last year. Valuation multiples are down and acquisition activity for 2019 is already 26% of last year’s total. —Recommended Link— How To Make Massive Gains When The Market Tumbles Industry veteran invites 50 investors to join him in the world’s only legal market hack that actually works… discover how to bring home an extra $37,000 in the next 365 days or less. Biotech is one of the few industries that should remain relatively immune from worries over the trade war and could be a bright spot in an otherwise volatile year. #-ad_banner-#In perhaps no other industry is stock-picking more important than in biotech. Investor sentiment could boost the entire group, but it will be the individual companies with breakthrough drugs that will provide outsized returns. Get Ready For The 2019 Biotech Boom The market was largely disappointed in biotech acquisitions last year and investors reflected their dissatisfaction in share prices. Passage of… Read More

In show business, you’re only as good as your last hit whether it’s a play, movie, or song. Oddly, the pharmaceutical business used to be the same way. As a young pup in the mid ’90s, I remember the veteran brokers loitering around the coffee machine jabbering about pharma stocks and the drugs the companies had in their pipelines. Remember, this was when Pfizer (NYSE: PFE) had just fired the opening salvo in the Baby Boom’s second sexual revolution with its blockbuster erectile dysfunction treatment Viagra. —Recommended Link— Learn How This New Medical Breakthrough Will Wipe Out Cancers, Heart Disease,… Read More

In show business, you’re only as good as your last hit whether it’s a play, movie, or song. Oddly, the pharmaceutical business used to be the same way. As a young pup in the mid ’90s, I remember the veteran brokers loitering around the coffee machine jabbering about pharma stocks and the drugs the companies had in their pipelines. Remember, this was when Pfizer (NYSE: PFE) had just fired the opening salvo in the Baby Boom’s second sexual revolution with its blockbuster erectile dysfunction treatment Viagra. —Recommended Link— Learn How This New Medical Breakthrough Will Wipe Out Cancers, Heart Disease, Alzheimer And Many Other Illnesses Read on and learn how you can make millions. And during the next two days only you will save 75%. However, over the last decade, as the trend of big pharma companies subbing out their research and development (R&D) to smaller, faster moving biotech companies has proliferated, you hear less chatter about Merck (NYSE: MRK) or Johnson & Johnson (NYSE: JNJ) having this or that drug in phase one, two, or three. #-ad_banner-#Then again, maybe I’m hanging out with the wrong people or not watching the right financial news shows. So, I decided to… Read More

With the recent market weakness, I think it prudent to follow up on what’s become a regular (and popular) feature. You see, while I mostly focus my attention on finding little-known, innovative companies that have the potential to deliver mega-returns to investors, I’ve consistently made the case that a big part of successful investing is often about what not to buy as well as what to buy. —Recommended Link— Legal? Completely. Simple? Definitely. Profitable? Hugely. You NEED to hear about this. If you’re looking for an innovative way to earn double and triple-digit gains then you don’t want to… Read More

With the recent market weakness, I think it prudent to follow up on what’s become a regular (and popular) feature. You see, while I mostly focus my attention on finding little-known, innovative companies that have the potential to deliver mega-returns to investors, I’ve consistently made the case that a big part of successful investing is often about what not to buy as well as what to buy. —Recommended Link— Legal? Completely. Simple? Definitely. Profitable? Hugely. You NEED to hear about this. If you’re looking for an innovative way to earn double and triple-digit gains then you don’t want to miss this. It’s completely legal and it doesn’t use options or leverage strategies. This is your opportunity to change the way you invest forever. The selloff in the stocks I spurned in this piece turned out to be much more devastating than in the market itself (which was horrific on its own). In the weeks between November 26 and December 26, the S&P 500 index declined 8%. During the same period, Diamond Offshore (NYSE: DO) lost 21.9%, Anheuser-Busch InBev (NYSE: BUD) lost 13.2%, Avon Products (NYSE: AVP) dropped 23.5% and Frontier Communications (NYSE: FTR) lost a whopping 35.4%. #-ad_banner-#I would… Read More

2019 will likely prove to be a pivotal year in the cryptocurrency space. Here are five reasons why: —Recommended Link— Discover The Secret To A Million Dollar Portfolio Ex-Economics professor and game-changing investment analyst Genia Turanova reveals how she’s helping hundreds of investors just like you fast-track their portfolio from barely breaking even to millionaire status. Want to know her secret? Click here now. 1. Bitcoin ETF Launches Finally, it appears that the Bitcoin ETF will become a reality in 2019. After simultaneously rejecting nine Bitcoin ETF proposals in August 2018, the SEC is poised to potentially issue… Read More

2019 will likely prove to be a pivotal year in the cryptocurrency space. Here are five reasons why: —Recommended Link— Discover The Secret To A Million Dollar Portfolio Ex-Economics professor and game-changing investment analyst Genia Turanova reveals how she’s helping hundreds of investors just like you fast-track their portfolio from barely breaking even to millionaire status. Want to know her secret? Click here now. 1. Bitcoin ETF Launches Finally, it appears that the Bitcoin ETF will become a reality in 2019. After simultaneously rejecting nine Bitcoin ETF proposals in August 2018, the SEC is poised to potentially issue an approval in 2019. #-ad_banner-#Shooting down launch ideas from ProShares, Direxion, and GraniteShares, the regulatory agency appears to be more concerned about the lack of volume on the Bitcoin future exchange rather than the actual value or utility of the underlying asset. The U.S. Securities and Exchange Commission (SEC) has made clear it is not making a judgment on the value of Bitcoin and the blockchain. “We emphasize that our disapproval does not rest on an evaluation of whether bitcoin or blockchain technology more generally, has utility or value as an innovation or an investment,” the SEC stated. The good… Read More

Knowing the hot trends is critical to earning big gains in the markets. Here are five you need to know… Catching significant trends is every investor’s goal. If you were fortunate enough to find any of the monster trends over the last decade; you know the money-making power of a massive, sustained market move. Millionaires are minted by understanding market/economic trends. —Recommended Link— Can You Use This Stock Market Hack To Make $30,000? “It pulled me out of the hole with recovery of $30,000 in just a couple of months.” Click here for details. One of the keys to… Read More

Knowing the hot trends is critical to earning big gains in the markets. Here are five you need to know… Catching significant trends is every investor’s goal. If you were fortunate enough to find any of the monster trends over the last decade; you know the money-making power of a massive, sustained market move. Millionaires are minted by understanding market/economic trends. —Recommended Link— Can You Use This Stock Market Hack To Make $30,000? “It pulled me out of the hole with recovery of $30,000 in just a couple of months.” Click here for details. One of the keys to riding the big waves is understanding the zeitgeist of the age. Every year has a slightly different twist on the overall decades-long economic themes. Themes like geopolitical tensions, the aging population, technological innovations, and the internet are examples of the major themes of the 21st century. Multiple sub-themes and unique trends pop up on a consistent basis. Knowing these sub-themes and unique trends are crucial to earning big gains in the financial markets. #-ad_banner-#Once you understand the burgeoning sub-themes and unique trends, the next step is to locate solid companies that are profiting from the trend. I like taking a… Read More